
Search
Filter Results
Displaying 71–80 of 1069 results
-
Dec 20, 2024
The company is also planning to conduct the clinical trial at sites in the EU.
-
Dec 20, 2024
Eye on the Cure Podcast | Episode 78: Dr. Sheldon Rowan
Dr. Rowan talks about the impact of the glycemic index, microbiome, and diet on the development of age-related macular degeneration and optimization of overall retinal health.
-
Dec 16, 2024
The company has also launched a natural history study of patients to inform the planned clinical trial.
-
Dec 16, 2024
Staying True to Music, Family, and Advocacy
Music duo Andrew & Polly have earned a GRAMMY nomination for their children’s album “Ahhhhh!” while also championing disability awareness and inclusivity. Andrew’s experience with Stargardt disease fuels their advocacy, inspiring others through their music, podcast, and dedication to research and community support.
-
Dec 13, 2024
Sepul Bio Launches Phase 2b Clinical Trial for USH2A RNA Therapy
Known as ultevursen, the USH2A RNA therapy was licensed from ProQR.
-
Dec 6, 2024
Eye on the Cure Podcast | Episode 77: Dr. Bob Bell
Dr. Bell, the CSO of Ascidian Therapeutics, talks about STELLAR, the company’s Phase ½ clinical trial for its emerging RNA-rewriting therapy for Stargardt disease (ABCA4 mutations).
-
Dec 6, 2024
The Eye on the Cure Podcast from the Foundation Fighting Blindness provides science information, news, and insights from the world of vision and retinal diseases. The podcasts are hosted by Ben Shaberman, vice president, science communications, and often include conversations with guests from the research and vision communities.
-
Dec 4, 2024
Microsoft Teams is a cloud-based collaboration tool that allows users to communicate and work together in real-time.
-
Dec 2, 2024
ARPA-H award establishes multi-disciplinary consortium of industry experts to address current limitations and advance innovative technologies for vision-restoring whole eye transplantation.
Goal to bring light to those who are blind through first-ever successful vision recovery in six whole eye transplants in humans by 2030.
-
This year, #GivingTuesday is December 3, 2024, and you can double your impact, fueling breakthroughs in blinding disease research!